secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0001641172-25-011391
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Q1 revenue up 5.9% to $2.28M; gross margin 68.5%, cash burn reduced 30%
------------------------------------------------------------------------------

- Revenue $2.28M vs $2.15M YoY (+5.9%), driven by select price increases and 94% jump in sales per FTE.
- Gross profit $1.6M (+28.5%); gross margin improved to 68.5% from 56.4% due to one-time accrual reduction and OvaWatch profitability.
- Operating expenses fell 19% to $4.8M (vs $5.9M); operating cash burn reduced 30% to $3.1M.
- Cash on hand rose to $3.3M from $1.8M; current liabilities decreased 30% to $3.8M.
- CEO Mike Buhle cited early traction under new leadership; ENDOInform R&D updates expected by end of 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000164117225011391/0001641172-25-011391-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000164117225011391/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011391

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer